Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment-Reference-Cited by-同舟云学术

Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment

Published:2016-03-30 Issue:6 Volume:5 Page:e1168549
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Saxon Jamie A.,Sherrill Taylor P.,Polosukhin Vasiliy V.,Sai Jiqing,Zaynagetdinov Rinat,McLoed Allyson G.,Gulleman Peter M.,Barham Whitney,Cheng Dong-Sheng,Hunt Raphael P.,Gleaves Linda A.,Richmond Ann,Young Lisa R.,Yull Fiona E.,Blackwell Timothy S.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1168549

Reference45 articles.

1. EGFR Mutations in Lung Adenocarcinomas

2. Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

3. Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity

4. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

5. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidermal growth factor receptor and programmed cell death‐1 expression levels in peripheral T cell subsets of patients with non‐small cell lung cancer;Scandinavian Journal of Immunology;2024-07-29

2. Morphine upregulates Toll-like receptor 4 expression and promotes melanomas in mice;Immunopharmacology and Immunotoxicology;2022-11-16

3. Macrophages-based immune-related risk score model for relapse prediction in stage I–III non-small cell lung cancer assessed by multiplex immunofluorescence;Translational Lung Cancer Research;2022-04

4. Next frontier in tumor immunotherapy: macrophage-mediated immune evasion;Biomarker Research;2021-10-09

5. Systemic Inflammatory Markers of Survival in Epidermal Growth Factor–Mutated Non–Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis;Clinical Lung Cancer;2021-09